A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants

NCT07532655 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: SYH2082 Injection
DRUG: Placebo

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.